IDO1 and non-small cell lung carcinoma: A single-arm Phase II trial involving induction chemotherapy followed by concurrent CRT in stage III NSCLC patients reported that the mean Kyn : Trp ratio increased after induction therapy or CRT and the study correlated the post-induction chemotherapy increase in IDO1 activity with worse OS (12).